学术探索
学术期刊
新闻热点
数据分析
智能评审

Discovery of alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

被引：352
作者：
Feng, Jun
Zhang, Zhiyuan
Wallace, Michael B.
Stafford, Jeffrey A.
Kaldor, Stephen W.
Kassel, Daniel B.
Navre, Marc
Shi, Lihong
Skene, Robert J.
Asakawa, Tomoko
Takeuchi, Koji
Xu, Rongda
Webb, David R.
Gwaltney, Stephen L., II
机构：
[1] Takeda San Diego Inc, San Diego, CA 92121 USA
[2] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Osaka, Japan
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 10期
关键词：
D O I：
10.1021/jm070104l
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Alogliptin is a potent, selective inhibitor of the serine protease dipeptidyl peptidase IV (DPP-4). Herein, we describe the structure-based design and optimization of alogliptin and related quinazolinone-based DPP-4 inhibitors. Following an oral dose, these noncovalent inhibitors provide sustained reduction of plasma DPP-4 activity and a lowering of blood glucose in animal models of diabetes. Alogliptin is currently undergoing phase III trials in patients with type 2 diabetes.
引用
收藏
页码：2297 / 2300
页数：4
相关论文
共 16 条
[11]   SELECTIVE N-FUNCTIONALIZATION OF 6-SUBSTITUTED-2-PYRIDONES [J].
LIU, H ;
KO, SB ;
JOSIEN, H ;
CURRAN, DP .
TETRAHEDRON LETTERS, 1995, 36 (49) :8917-8920
[12]   Privileged structure-based quinazolinone natural product-templated libraries: Identification of novel tubulin polymerization inhibitors [J].
Liu, JF ;
Wilson, CJ ;
Ye, P ;
Sprague, K ;
Sargent, K ;
Si, Y ;
Beletsky, G ;
Yohannes, D ;
Ng, SC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) :686-690
[13]  
Livingston JN, 1999, ANNU REP MED CHEM, V34, P189
[14]  
PRATLEY R, 2004, P 64 ADA ORL FL JUN
[15]   1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine:: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties [J].
Villhauer, EB ;
Brinkman, JA ;
Naderi, GB ;
Burkey, BF ;
Dunning, BE ;
Prasad, K ;
Mangold, BL ;
Russell, ME ;
Hughes, TE .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) :2774-2789
[16]   Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study [J].
Zander, M ;
Madsbad, S ;
Madsen, JL ;
Holst, JJ .
LANCET, 2002, 359 (9309) :824-830
12